Ultragenyx Pharmaceutical Inc. Insider Trading for June 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for June 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,875 | 0 | 3,750 | 1.9 K to 3.8 K (+100.00 %) |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Grant | A | 0.00 | 1,875 | 0 | 3,750 | 1.9 K to 3.8 K (+100.00 %) |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Grant | A | 0.00 | 1,875 | 0 | 3,750 | 1.9 K to 3.8 K (+100.00 %) |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Grant | A | 0.00 | 1,875 | 0 | 15,069 | 13.2 K to 15.1 K (+14.21 %) |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Grant | A | 0.00 | 1,875 | 0 | 3,750 | 1.9 K to 3.8 K (+100.00 %) |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Grant | A | 0.00 | 1,875 | 0 | 1,875 | 0 to 1.9 K |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Grant | A | 0.00 | 1,875 | 0 | 61,860 | 60 K to 61.9 K (+3.13 %) |
| Jun 21 2017 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Payment of Exercise | F | 63.38 | 705 | 44,683 | 8,795 | 9.5 K to 8.8 K (-7.42 %) |
| Jun 01 2017 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Payment of Exercise | F | 56.61 | 320 | 18,115 | 17,047 | 17.4 K to 17 K (-1.84 %) |
| Jun 01 2017 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 56.61 | 282 | 15,964 | 10,939 | 11.2 K to 10.9 K (-2.51 %) |
| Jun 01 2017 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Payment of Exercise | F | 56.61 | 1,006 | 56,950 | 430,569 | 431.6 K to 430.6 K (-0.23 %) |
| Jun 01 2017 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Payment of Exercise | F | 56.61 | 376 | 21,285 | 76,228 | 76.6 K to 76.2 K (-0.49 %) |
| Jun 01 2017 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Payment of Exercise | F | 56.61 | 282 | 15,964 | 12,588 | 12.9 K to 12.6 K (-2.19 %) |
| Jun 01 2017 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Payment of Exercise | F | 56.61 | 376 | 21,285 | 55,470 | 55.8 K to 55.5 K (-0.67 %) |